Sudeep Pharma Limited has made the audio recording of its Q3FY26 earnings call available to stakeholders following the successful completion of the conference call on February 9, 2026. The pharmaceutical company announced the availability through a regulatory filing under Regulation 30 of the SEBI Listing Regulations, 2015.

Earnings Call Details and Access

The company conducted its earnings call as scheduled on February 9, 2026, at 11:00 AM IST, focusing on operational and financial performance for the quarter and nine months ended December 31, 2025. The complete audio recording has been uploaded on the company's official website for immediate access by investors, analysts, and other stakeholders.

Regulatory Compliance and Documentation

Sudeep Pharma has informed both NSE and BSE about the audio recording availability through proper regulatory channels. Company Secretary and Compliance Officer Dimple Mehta signed the official communication on February 9, 2026, ensuring full compliance with listing regulations.

Next Steps and Additional Documentation

The company has indicated that a detailed transcript of the earnings call will be submitted separately to the stock exchanges. This will provide stakeholders with comprehensive written documentation of the management discussions and Q&A session that took place during the conference call.

Sudeep Pharma Limited has formally notified stock exchanges about the resignation of John Garcia, Vice President of Sales & Supply Chain at its wholly owned subsidiary Sudeep Pharma USA Inc, effective February 6, 2026.

Regulatory Compliance Filing

The company submitted the mandatory disclosure to both National Stock Exchange of India Limited (NSE) and BSE Limited on February 5, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Company Secretary & Compliance Officer Dimple Mehta.

Official Documentation

According to the formal resignation letter submitted to the company, Garcia tendered his resignation on February 4, 2026, with his last working day scheduled for Friday, February 6, 2026. In his resignation letter addressed to Sendhil Pani, Garcia expressed gratitude for the opportunities provided and committed to ensuring a smooth transition during his final weeks.

Regulatory Disclosure Requirements

The company's filing includes comprehensive annexures as mandated by SEBI regulations. The disclosure confirms that Garcia is resigning to pursue new challenges and opportunities outside the organization. As a Senior Management Personnel (SMP) of the wholly owned subsidiary, his resignation requires formal notification to stock exchanges under the listing regulations.

Transition Planning

Garcia's departure affects critical business functions within the US subsidiary, particularly sales operations and supply chain management. In his resignation letter, he emphasized his commitment to completing outstanding tasks and facilitating the handover of responsibilities to the remaining team members during the transition period.